| Comparative biophysical studies of sartan class drug molecules losartan and candesartan (CV-11974) with membrane bilayers C Fotakis, D Christodouleas, P Zoumpoulakis, E Kritsi, NP Benetis, ... The Journal of Physical Chemistry B 115 (19), 6180-6192, 2011 | 42 | 2011 |
| Novel quinolinone–pyrazoline hybrids: Synthesis and evaluation of antioxidant and lipoxygenase inhibitory activity I Kostopoulou, A Diassakou, E Kavetsou, E Kritsi, P Zoumpoulakis, ... Molecular Diversity 25, 723-740, 2021 | 28 | 2021 |
| Comparative study of the AT1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers C Fotakis, G Megariotis, D Christodouleas, E Kritsi, P Zoumpoulakis, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1818 (12), 3107-3120, 2012 | 27 | 2012 |
| Exploring the 2′-hydroxy-chalcone framework for the development of dual antioxidant and soybean lipoxygenase inhibitory agents I Kostopoulou, A Tzani, NI Polyzos, MA Karadendrou, E Kritsi, E Pontiki, ... Molecules 26 (9), 2777, 2021 | 24 | 2021 |
| Novel Hit Compounds as Putative Antifungals: The Case of Aspergillus fumigatus E Kritsi, MT Matsoukas, C Potamitis, A Detsi, M Ivanov, M Sokovic, ... Molecules 24 (21), 3853, 2019 | 24 | 2019 |
| Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II type 1 G-protein coupled receptor T F Kellici, D Ntountaniotis, E Kritsi, M Zervou, P Zoumpoulakis, ... Current Medicinal Chemistry 23 (1), 36-59, 2016 | 22 | 2016 |
| Design and development of novel nutraceuticals: Current trends and methodologies T Tsiaka, E Kritsi, K Tsiantas, P Christodoulou, VJ Sinanoglou, ... Nutraceuticals 2 (2), 71-90, 2022 | 19 | 2022 |
| Antimicrobial/Antibiofilm Activity and Cytotoxic Studies of β‐Thujaplicin Derivatives T Fotopoulou, A Ćirić, E Kritsi, RC Calhelha, ICFR Ferreira, M Soković, ... Archiv der Pharmazie 349 (9), 698-709, 2016 | 19 | 2016 |
| BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis K Koumaki, G Kontogianni, V Kosmidou, F Pahitsa, E Kritsi, M Zervou, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (4), 166061, 2021 | 18 | 2021 |
| The triazole ring as a privileged scaffold for putative antifungals: Synthesis and evaluation of a series of new analogues G Zoidis, E Kritsi, P Lecinska, M Ivanov, P Zoumpoulakis, M Sokovic, ... ChemMedChem 16 (1), 134-144, 2021 | 18 | 2021 |
| Curcumin Derivatives as Potential Mosquito Larvicidal Agents against Two Mosquito Vectors, Culex pipiens and Aedes albopictus D Matiadis, PGV Liggri, E Kritsi, N Tzioumaki, P Zoumpoulakis, ... International Journal of Molecular Sciences 22 (16), 8915, 2021 | 17 | 2021 |
| Green synthesis of bis-(β-dicarbonyl)-methane derivatives and biological evaluation as putative anticandidial agents A Tzani, C Vaitsis, E Kritsi, M Smiljkovic, M Sokovic, P Zoumpoulakis, ... Journal of Molecular Structure 1216, 128276, 2020 | 15 | 2020 |
| Effects of non-polar dietary and endogenous lipids on gut microbiota alterations: the role of lipidomics K Tsiantas, SJ Konteles, E Kritsi, VJ Sinanoglou, T Tsiaka, ... International Journal of Molecular Sciences 23 (8), 4070, 2022 | 14 | 2022 |
| Nitrate Esters of Heteroaromatic Compounds as Candida albicans CYP51 Enzyme Inhibitors M Smiljkovic, MT Matsoukas, E Kritsi, U Zelenko, SG Grdadolnik, ... ChemMedChem 13 (3), 251-258, 2018 | 14 | 2018 |
| In Vitro and In Silico Studies to Assess Edible Flowers’ Antioxidant Activities E Kritsi, T Tsiaka, AG Ioannou, V Mantanika, IF Strati, I Panderi, ... Applied Sciences 12 (14), 7331, 2022 | 13 | 2022 |
| Towards the optimization of microwave-assisted extraction and the assessment of chemical profile, antioxidant and antimicrobial activity of wine lees extracts D Tagkouli, T Tsiaka, E Kritsi, M Soković, VJ Sinanoglou, DZ Lantzouraki, ... Molecules 27 (7), 2189, 2022 | 13 | 2022 |
| Quality assessment of banana ripening stages by combining analytical methods and image analysis VJ Sinanoglou, T Tsiaka, K Aouant, E Mouka, G Ladika, E Kritsi, ... Applied Sciences 13 (6), 3533, 2023 | 12 | 2023 |
| Optimization of ultrasound-and microwave-assisted extraction for the determination of phenolic compounds in peach byproducts using experimental design and liquid chromatography … T Tsiaka, DZ Lantzouraki, G Polychronaki, G Sotiroudis, E Kritsi, ... Molecules 28 (2), 518, 2023 | 9 | 2023 |
| Molecular insights into the AT1 antagonism based on biophysical and in silico studies of telmisartan E Kritsi, C Potamitis, S Durdagi, P Zoumpoulakis, S Golic Grdadolnik, ... Medicinal Chemistry Research 22, 4842-4857, 2013 | 9 | 2013 |
| Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82–98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II G Deraos, E Kritsi, MT Matsoukas, K Christopoulou, H Kalbacher, ... Brain Sciences 8 (12), 213, 2018 | 8 | 2018 |
